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Identity 
Other names: C-C CKR-9; CC-CKR-9; CCR-9; 
CDw199; Ckbeta-15; CMKBR9; GPR-9-6; GPR28 
HGNC (Hugo): CCR9 
Location: 3p21.31 
Note: CCR9 is a G protein-coupled receptor with 
specifi-city for a CC chemokine CCL25 (originally 
described as thymus-expressed chemokine or TECK) 




The gene and mRNA for CCR9 are 16.6 and 2.7 kb in 
length, respectively. 
Description 
The CCR9 gene consists of three exons, the second and 
third exons being the coding-exons. Alternative 
splicing of the gene generates two distinct mRNAs, 
CCR9-A and CCR9-B. The CCR9-A cDNA was the 
first to be cloned. 
Transcription 
The CCR9-A mRNA is encoded by the three exons, 
while the CCR9-B lacks the sequence derived from the 
second exon of 49 bp. The CCR9 mRNAs are 
expressed predominantly in the thymus. Among the cell 
lines tested, T cell leukemia line MOLT-4 and HTLV-
1+ T cells express CCR9 mRNA. The CCR9-A mRNA 
is expressed at ~10-fold higher levels than CCR9-B 





CCR9-A: 369 amino acids, 42015 Da. 
CCR9-B: 357 amino acids, 40712 Da. 
Description 
CCR9 is a member of the seven transmembrane G 
protein-coupled receptor superfamily, and is the single 
receptor for chemokine CCL25. 
 
The CCR9 gene generates two distinct mRNAs. 
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Expression 
CCR9 is present on thymocytes as well as on 
intraepithelial and lamina propria lymphocytes of the 
small intestine. A small subset of lymphocytes in the
colon is also expressing CCR9. 
Localisation 
Cell membrane; Multi-pass membrane protein. 
Function 
CCR9 mediates chemotaxis to CCL25, which is 
selectively expressed in the thymus and small intesti , 
and plays an important role in the recruitment of T cells 
into gut mucosa. Dendritic cells derived from gut-
associated lymphoid tissues as well as retinoic acid 
have been shown to induce the expression of 
alpha4beta7 integrin and CCR9 on T cells, resulting in 
their preferential homing to the gut. Although CCR9 
deletion in mice has no major effects on the intrathymic 
T-cell develop-ment, down-regulation of CCR9 on 
activated CD4+CD8+ double positive thymocytes has 
been shown to allow the migration of maturing thymo-
cytes from the cortex to the medulla. 
The EC50 of CCL25 for CCR9-A is somewhat lower 
than that for CCR9-B. CCR9-A-expressing cells are 
therefore more responsive to CCL25 than the cells 
expressing CCR9-B in chemotaxis and calcium influx 
experiments. 
Homology 
CCR9 is closely related to the chemokine receptors 
CCR6, CCR7, and CXCR6. 
Implicated in 
T-cell acute lymphocytic leukemia (T-
ALL) 
Oncogenesis 
Qiuping et al. (2003) assessed the expression of CCR9 
in 21 T-ALL and 17 "T-cell chronic lymphocytic 
leukemia" (T-CLL) cases, and found that functionally 
active CCR9 was selectively and frequently expressed 
on T-ALL CD4+ T cells and was moderately expressed 
on T-CLL CD4+ T cells. 
Annels et al. (2004) investigated homing receptor 
expression on the blast cells of 11 pediatric T-ALL 
patients. They found that CCR9 and CD103 (alphaE 
integrin) were expressed at high levels on T-ALL cells 
of one patient. This patient later switched to a clona ly 
related acute myeloid leuke-mia during treatment, ad
the relapse of leukemia was confined to the gut. This 
study suggests a role of CCR9 in infiltration of 
leukemic cells into the gut. 
Adult T-cell leukemia (ATL) 
Oncogenesis 
ATL frequently invades the gastrointestinal tract. 
Nagakubo et al. (2007) examined CCR9 expression in  
five ATL-derived cell lines and 10 blood samples from 
ATL patients containing leukemic cells at high levels. 
Although all ATL cell lines were CCR9-positive, fresh 
ATL cells derived from patients were mostly negative. 
However, ATL cells became readily positive for CCR9 
mRNA after one-day culture in parallel with the 
expression of Tax mRNA. This study suggests that 
CCR9 is inducible in ATL cells and may play a role in 
the high incidence of ATL cell invasion into the 
gastrointestinal tract. 
Melanoma metastasis to the small 
intestine 
Oncogenesis 
Letsch et al. (2004) assessed CCR9 expression in 20 
melanoma cell lines. The CCR9-positive cell lines were 
established from metastases to small intestine (n =3), 
lymph node (n = 4), and skin (n = 1). Only melanoma 
cell lines derived from small intestinal metastases, 
however, were responsive to CCL25. This study 
correlated functional expression of CCR9 with 
melanoma metastasis to the small intestine. 
Amersi et al. (2008) assessed CCR9 expression in 
primary (n = 23) and metastatic (n = 198) melanomas, 
and melanoma lines derived from small intestinal 
metastases (n = 8). CCR9 expres-sion was observed in 
88 of 102 metastatic melanomas from the small 
intestine, 8 of 8 mela-noma lines derived from small 
intestine metastasis, but none of 96 metastatic 
melanomas from other sites. In addition, 11 of 23 
primary melanomas were CCR9-positive and 7 of these 
later developed small intestinal metastases. This study 
suggests that CCR9 has a role in melanoma metastasis 
to the small intestine. 
Melanoma metastasis 
Oncogenesis 
Seidl et al. (2007) investigated expression of eight 
chemokine receptors including CCR9 in 51 tissue 
samples of melanocytic origin. CCR9 mRNA was 
observed in more than half of the melanocytic lesion  
including lymph node metastases and visceral 
metastases. The authors concluded that there is no clear 
trend toward an association between the CCR9 
expression levels and melanoma progression. 
Prostate cancer metastasis 
Oncogenesis 
Singh et al. (2004) investigated CCR9 expression in 
two prostate cancer cell lines. Both cell lines expr ssed 
CCR9. This study suggests that expres-sion and 
activation of CCR9 affect prostate cancer metastasis. 
Small intestinal Crohn's disease 
Oncogenesis 
Papadakis et al. (2001) found that CCR9+ T cells were 
markedly elevated in the peripheral blood of patients 
with Crohn's disease but not those with purely colonic  
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Crohn's disease. This study suggests selective 
involvement of CCR9 in the pathogenesis of small 
bowel Crohn's disease. 
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